These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 9351980)
1. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Zwart R; Vijverberg HP Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980 [TBL] [Abstract][Full Text] [Related]
2. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202 [TBL] [Abstract][Full Text] [Related]
3. Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine. González-Rubio JM; García de Diego AM; Egea J; Olivares R; Rojo J; Gandía L; García AG; Hernández-Guijo JM Eur J Pharmacol; 2006 Mar; 535(1-3):13-24. PubMed ID: 16530180 [TBL] [Abstract][Full Text] [Related]
4. Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine receptors by choline. Zwart R; Vijverberg HP Eur J Pharmacol; 2000 Mar; 393(1-3):209-14. PubMed ID: 10771015 [TBL] [Abstract][Full Text] [Related]
5. Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors. Tsuneki H; You Y; Toyooka N; Kagawa S; Kobayashi S; Sasaoka T; Nemoto H; Kimura I; Dani JA Mol Pharmacol; 2004 Oct; 66(4):1061-9. PubMed ID: 15258256 [TBL] [Abstract][Full Text] [Related]
6. Potentiation and inhibition of subtypes of neuronal nicotinic acetylcholine receptors by Pb2+. Zwart R; Van Kleef RG; Milikan JM; Oortgiesen M; Vijverberg HP Eur J Pharmacol; 1995 Nov; 291(3):399-406. PubMed ID: 8719426 [TBL] [Abstract][Full Text] [Related]
7. Nicotinic acetylcholine receptors of the neuronal type occur in the plasma membrane of sea urchin eggs. Ivonnet PI; Chambers EL Zygote; 1997 Aug; 5(3):277-87. PubMed ID: 9460914 [TBL] [Abstract][Full Text] [Related]
8. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine. Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686 [TBL] [Abstract][Full Text] [Related]
9. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Matsubayashi H; Inoue A; Amano T; Seki T; Nakata Y; Sasa M; Sakai N Brain Res Mol Brain Res; 2004 Oct; 129(1-2):1-7. PubMed ID: 15469877 [TBL] [Abstract][Full Text] [Related]
10. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207 [TBL] [Abstract][Full Text] [Related]
12. Interactions of atropine with heterologously expressed and native alpha 3 subunit-containing nicotinic acetylcholine receptors. Parker JC; Sarkar D; Quick MW; Lester RA Br J Pharmacol; 2003 Mar; 138(5):801-10. PubMed ID: 12642381 [TBL] [Abstract][Full Text] [Related]
13. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine. Yamakura T; Chavez-Noriega LE; Harris RA Anesthesiology; 2000 Apr; 92(4):1144-53. PubMed ID: 10754635 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of nicotinic acetylcholine receptors by bicuculline. Demuro A; Palma E; Eusebi F; Miledi R Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149 [TBL] [Abstract][Full Text] [Related]
15. Block of nicotinic acetylcholine receptors by philanthotoxins is strongly dependent on their subunit composition. Kachel HS; Patel RN; Franzyk H; Mellor IR Sci Rep; 2016 Nov; 6():38116. PubMed ID: 27901080 [TBL] [Abstract][Full Text] [Related]
16. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544 [TBL] [Abstract][Full Text] [Related]
17. Molecular Determinants of α3β4 Nicotinic Acetylcholine Receptors Inhibition by Triterpenoids. Eom S; Kim YS; Lee SB; Noh S; Yeom HD; Bae H; Lee JH Biol Pharm Bull; 2018; 41(1):65-72. PubMed ID: 29311484 [TBL] [Abstract][Full Text] [Related]
18. Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant. Briggs CA; McKenna DG; Monteggia LM; Touma E; Roch JM; Arneric SP; Gopalakrishnan M; Sullivan JP Eur J Pharmacol; 1999 Feb; 366(2-3):301-8. PubMed ID: 10082212 [TBL] [Abstract][Full Text] [Related]
19. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells. Stauderman KA; Mahaffy LS; Akong M; Veliçelebi G; Chavez-Noriega LE; Crona JH; Johnson EC; Elliott KJ; Gillespie A; Reid RT; Adams P; Harpold MM; Corey-Naeve J J Pharmacol Exp Ther; 1998 Feb; 284(2):777-89. PubMed ID: 9454827 [TBL] [Abstract][Full Text] [Related]